Windlas Biotech Ltd Performance
Day's Low
Day's High
₹921.3₹98552 Week's Low
52 Week's High
₹400.1₹1,198.25
| Returns % | |
| 1 Month Return | -4.39 % |
| 3 Month Return | + 16.38 % |
| 1 Year Return | + 120.83 % |
| Market Stats | |
| Previous Close | ₹958.95 |
| Open | ₹959.00 |
| Volume | 43.09K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,004.24Cr |
Windlas Biotech Ltd Key Statistics
| P/E Ratio | 32.63 |
| PEG Ratio | 4.5 |
| Market Cap | ₹2,004.24 Cr |
| P/B Ratio | 2.37 |
| EPS | 27.98 |
| Dividend Yield | 1.07 |
| Sector | Pharmaceuticals |
| ROE | 13.63 |
Windlas Biotech Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,004.24 Cr | 27.11% | 0.51 | ₹58 Cr | ₹630 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Windlas Biotech Ltd
Share Price: ₹926.60 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹2,004.24Cr as of today
Revenue: ₹187.00Cr as on September 2024 (Q3 24)
Net Profit: ₹15.66Cr as on September 2024 (Q3 24)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
| Organisation | Windlas Biotech Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Windlas Biotech Ltd
Windlas Biotech Reports Strong Q1 Growth and Future Prospects - 08 Oct, 2024
Windlas Biotech achieved a 21% year-on-year revenue growth in Q1 FY25, reaching ₹1.8 billion. Management highlighted benefits from government healthcare initiatives and expects margin improvements due to increased capacity utilization and a new injectable manufacturing plant, with exports starting in FY26.
Insights on Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 8 quarters, 121.87 Cr → 191.84 Cr (in ₹), with an average increase of 6.2% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.59% to 2.00% in Sep 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 13.48 Cr → 15.66 Cr (in ₹), with an average increase of 13.9% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 25.55% to 25.91% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 62.51% of holdings in Sep 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, WINDLAS stock has moved down by -6.5%
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 8.70% to 7.57% in Sep 2024 quarter
Windlas Biotech Ltd Financials
Index Inclusions
Windlas Biotech Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 62.51% | 0.00 | |
| Foreign Institutions | 2% | 25.65 | |
| Mutual Funds | 7.57% | ||
| Retail Investors | 25.91% | 1.39 | |
| Others | 2.01% | 22.00 |
Windlas Biotech Ltd Key Indicators
Windlas Biotech Ltd Valuation
Windlas Biotech Ltd in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (32.63x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (38.40x)
November 6, 2024
Windlas Biotech Ltd Earnings and Dividends
Windlas Biotech Ltd Earnings Results
Windlas Biotech Ltd’s net profit jumped 11.62% since last year same period to ₹15.66Cr in the Q2 2024-2025. On a quarterly growth basis, Windlas Biotech Ltd has generated 16.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsWindlas Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Windlas Biotech Ltd has declared dividend of ₹5.50 - translating a dividend yield of 0.59%.
Read More about Dividends
Windlas Biotech Ltd Technicals Summary
Bearish
Neutral
Bullish
Windlas Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Windlas Biotech Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Windlas Biotech Ltd shares.
Windlas Biotech Ltd (WINDLAS) share price today is ₹926.6
Windlas Biotech Ltd is listed on NSE
Windlas Biotech Ltd is listed on BSE
- Today’s highest price of Windlas Biotech Ltd is ₹985.
- Today’s lowest price of Windlas Biotech Ltd is ₹921.3.
PE Ratio of Windlas Biotech Ltd is 32.63
PE ratio = Windlas Biotech Ltd Market price per share / Windlas Biotech Ltd Earnings per share
Today’s traded volume of Windlas Biotech Ltd(WINDLAS) is 43.09K.
Today’s market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹2004.24Cr.
| Windlas Biotech Ltd(WINDLAS | Price |
|---|---|
52 Week High | ₹1198.25 |
52 Week Low | ₹400.1 |
Windlas Biotech Ltd(WINDLAS) share price is ₹926.6. It is down -22.67% from its 52 Week High price of ₹1198.25
Windlas Biotech Ltd(WINDLAS) share price is ₹926.6. It is up 131.59% from its 52 Week Low price of ₹400.1
| Windlas Biotech Ltd(WINDLAS | Returns |
|---|---|
1 Day Returns | -32.35% |
1 Month Returns | -4.39% |
3 Month Returns | 16.38% |
1 Year Returns | 120.83% |